Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
GlobalData on MSN5d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesThe US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a ...
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
This report covers recent health news, including Robert F. Kennedy Jr.'s legal fees from Merck litigations, rejections of a ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback